核糖体
癌变
生物
核糖体蛋白
核糖体生物发生
细胞生物学
翻译(生物学)
转移
多形体
癌细胞
表观遗传学
核糖体RNA
癌症研究
癌症
核糖核酸
信使核糖核酸
遗传学
基因
作者
Sreepriya Pk,Joshua Freimanis,A. Thomas Kovala,Amadeo Mark Parissenti
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2025-08-29
卷期号:17 (17): 2825-2825
被引量:6
标识
DOI:10.3390/cancers17172825
摘要
Protein translation by ribosomes is one of the most energetically costly cellular processes. Consequently, the number and activity of ribosomes in cells and tissues are precisely tailored to match metabolic demands. While ribosomal proteins (RPs) play essential roles in facilitating and regulating the translation of mRNA transcripts into protein, there is increasing evidence that free RPs not bound to ribosomes can play important roles in cellular regulation. Often, free RPs act as tumour suppressors by multiple mechanisms, for example, by inducing cell cycle arrest through their ability to bind and inhibit MDM2-mediated p53 degradation. Dysregulation of these RPs, however, can result in various diseases like Diamond-Blackfan anemia, ribosomopathies, and other diseases. In cancer, epigenetic modifications, altered transcription, and processing defects in the rRNAs create "onco-ribosomes" that strongly support tumour cell replication, invasion and metastasis. In this context, free RPs in tumour cells (often mutated or post-translationally modified) further promote tumour cell proliferation, invasion, and metastasis. This review focuses specifically on extra-ribosomal roles for RPs, where depending upon cellular context, they act outside of the ribosome to either suppress tumorigenesis in normal tissues or promote tumour proliferation and progression. This new understanding of the interplay between RPs and pathways suppressing or promoting tumorigenesis further emphasizes why the ribosome is increasingly being seen as an important therapeutic target in human cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI